Resveratrol and Alzheimer's disease. From molecular pathophysiology to clinical trials

被引：39
|
作者：
Drygalski, Krzysztof [1 ]
Fereniec, Eliza [2 ]
Korycinski, Krzysztof [1 ]
Chomentowski, Andrzej [1 ]
Kielczewska, Aleksandra [1 ]
Odrzygozdz, Cezary [3 ]
Modzelewska, Beata [1 ]
机构：
[1] Med Univ Bialystok, Dept Biophys, Ul Mickiewicza 2A, PL-15089 Bialystok, Poland
[2] Nicolaus Copernicus Univ Torun, Dept Clin Pathomorphol, Coll Med Bydgoszcz, Ul Curie Sklodowskiej 9, PL-85094 Bydgoszcz, Poland
[3] Polish Acad Sci, Inst Human Genet, Dept Nucle Acid Funct, Ul Strzeszynska 32, PL-60479 Poznan, Poland
来源：
EXPERIMENTAL GERONTOLOGY | 2018年 / 113卷
关键词：
AMYLOID PRECURSOR PROTEIN; END-PRODUCTS; OXIDATIVE STRESS; MEMORY IMPAIRMENT; GLYCEMIC CONTROL; ALPHA-SECRETASE; NITRIC-OXIDE; TAU; EXPRESSION; BACE1;
D O I：
10.1016/j.exger.2018.09.019
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
[No abstract available]
引用
收藏
页码：36 / 47
页数：12
相关论文
共 50 条
  • [41] The role of astroglia in Alzheimer's disease: pathophysiology and clinical implications
    Arranz, Amaia M.
    De Strooper, Bart
    LANCET NEUROLOGY, 2019, 18 (04): : 406 - 414
  • [42] Alzheimer's disease: clinical update on epidemiology, pathophysiology and diagnosis
    Eratne, Dhamidhu
    Loi, Samantha M.
    Farrand, Sarah
    Kelso, Wendy
    Velakoulis, Dennis
    Looi, Jeffrey C. L.
    AUSTRALASIAN PSYCHIATRY, 2018, 26 (04) : 347 - 357
  • [43] Alzheimer's disease - Clinical trials and the logic of clinical purpose
    Karlawish, Jason
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (15): : 1604 - 1606
  • [44] Neurotrophins -: From pathophysiology to treatment in Alzheimer's disease
    Schulte-Herbrueggen, Olaf
    Jockers-Scheruebl, Maria C.
    Hellweg, Rainer
    CURRENT ALZHEIMER RESEARCH, 2008, 5 (01) : 38 - 44
  • [45] Molecular and cellular pathophysiology of sickle cell disease.
    Labie, D
    Elion, J
    PATHOLOGIE BIOLOGIE, 1999, 47 (01): : 7 - 12
  • [46] THE ROLE OF EEG IN CLINICAL TRIALS ON ALZHEIMER'S DISEASE
    van Straaten, Ilse
    Scheltens, P.
    Stam, C. J.
    NEUROBIOLOGY OF AGING, 2014, 35 : S23 - S23
  • [47] Applications of Alzheimer's disease staging to clinical trials
    Therriault, Joseph
    Gauthier, Serge
    Rosa-Neto, Pedro
    AGING-US, 2023, 15 (01): : 1 - 2
  • [48] Biochemical markers in Alzheimer's disease clinical trials
    Zetterberg, Henrik
    Mattsson, Niklas
    Shaw, Les M.
    Blennow, Kaj
    BIOMARKERS IN MEDICINE, 2010, 4 (01) : 91 - 98
  • [49] Clinical Trials of Intravenous Immunoglobulin for Alzheimer’s Disease
    Norman Relkin
    Journal of Clinical Immunology, 2014, 34 : 74 - 79
  • [50] Therapeutic strategies for Alzheimer’s disease in clinical trials
    Justyna Godyń
    Jakub Jończyk
    Dawid Panek
    Barbara Malawska
    Pharmacological Reports, 2016, 68 : 127 - 138
12345